Global Remdesivir Market, By Dosage Form, By Route of Administration, By Patient Age, By Application, By Distribution Channel, By Region, Competition Forecast & Opportunities, 2026

Global Remdesivir Market, By Dosage Form, By Route of Administration, By Patient Age, By Application, By Distribution Channel, By Region, Competition Forecast & Opportunities, 2026

  • August 2021 •
  • 114 pages •
  • Report ID: 6128263 •
  • Format: PDF
Global Remdesivir Market, By Dosage Form (Lyophilized Solution, Frozen Solution), By Route of Administration (Intravenous, Inhalation), By Patient Age (Geriatric, Adult, Pediatric), By Application (SARS-CoV-2 (COVID-19), MERS-CoV, Ebola, SARS-CoV), By Distribution Channel (Hospitals, Clinics, Drug Stores and Pharmacies), By Region, Competition Forecast & Opportunities, 2026

Global Remdesivir market is expected to reach USD9913.38 million by 2026. Remdesivir, a drug originally developed by Gilead Sciences, Inc. for the treatment of Ebola, is an antiviral medication belonging to the drug class of protease inhibitors. Remdesivir is a nucleotide analog particularly of adenosine, which shuts down the viral replication process by inhibiting the activity of an important viral enzyme RNA-dependent RNA polymerase. The drug basically causes mutation in viral genome and blocks polymerase enzymes function, which brings about premature termination of viral replication.

The global remdesivir market is driven by the increasing prevalence of COVID-19 pandemic across different parts of the globe.Remdesivir has been found to be effective in treating novel coronavirus disease patients across different parts of the globe.

The Chinese have also been using the drug on compassionate use basis.Additionally, the drug was also used on the very first COVID-19 patient in the US, a young man in Snohomish country in Washington.

He was given the drug when his condition worsened, and signs of improvement were observed on the very next day in his condition after the drug administration.A Californian patient, who the doctors thought, will not survive, also recovered after getting remdesivir.

Promising results were also observed in Japan on 14 patients. After such cases and evidences, the US Food and Drug Administration granted approval to Remdesivir in Oct 2020 and the world is hoping that it will emerge out as a successful coronavirus treatment in coming years as well.

The global remdesivir market is segmented based on dosage form, route of administration, patient age, distribution channel, application, company, and region.Based on dosage form, the market can be categorized into frozen solution, and lyophilized solution.

The lyophilized segment is expected to hold significant market share on account of their longer shelf life. Additionally, they are cost effective, safe and an effective way to deliver medication.

Regionally, Asia Pacific is expected to witness significant growth during the forecast period in the overall remdesivir market owing to increasing number of COVID-19 patients and huge number of hospitalization cases along with increasing demand for remdesivir for the treatment of COVID-19.

Major players operating in the global remdesivir market include Gilead Sciences, Inc., Cipla Ltd., Hetero Labs Ltd., Meda Pharma SA (VIATRIS Pharmaceuticals Ltd.), Dr Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cadila Healthcare Ltd., Jubilant Pharmova Ltd., Eva Pharma, Ferozsons Laboratories and others.

Years considered for this report:

Base Year: 2020
Estimated Year: 2021E
Forecast Period: 2022F–2026F

Objective of the Study:

• To analyze and estimate the market size of global remdesivir market in 2020.
• To estimate and forecast the market size of global remdesivir market from 2021 to 2026 and growth rate until 2026.
• To classify and forecast global remdesivir market based on dosage form, route of administration, patient age, application, distribution channel, company, and regional distribution.
• To identify dominant region or segment in the global remdesivir market.
• To identify drivers and challenges for global remdesivir market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global remdesivir market.
• To conduct pricing analysis for global remdesivir market.
• To identify and analyze the profile of leading players operating in global remdesivir market.
• To identify key sustainable strategies adopted by market players in global remdesivir market.
The analyst performed both primary as well as exhaustive secondary research for this study.Initially, the analyst sourced a list of manufacturers across the globe.

Subsequently, the analyst conducted primary research surveys with the identified companies.While interviewing, the respondents were also enquired about their competitors.

Through this technique, the analyst could include the manufacturers which could not be identified due to the limitations of secondary research. The analyst examined the manufacturers, distribution channels and presence of all major players across the globe.
The analyst calculated the market size of global remdesivir market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The analyst sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size.

Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the analyst.

Key Target Audience:

• Remdesivir manufacturers, suppliers, distributors and other stakeholders
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to remdesivir
• Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global remdesivir market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• Global Remdesivir Market, By Dosage Form:
o Lyophilized Solution
o Frozen Solution
• Global Remdesivir Market, By Route of Administration:
o Intravenous
o Inhalation
• Global Remdesivir Market, By Patient Age:
o Geriatric
o Adult
o Pediatric
• Global Remdesivir Market, By Application:
o SARS-CoV-2 (COVID-19)
o MERS-CoV
o Ebola
o SARS-CoV
• Global Remdesivir Market, By Distribution Channel:
o Hospitals
o Clinics
o Drug Stores and Pharmacies
• Global Remdesivir Market, By Region:
o North America
United States
Mexico
Canada
o Asia-Pacific
India
Japan
China
South Korea
Australia
o Europe
France
United Kingdom
Italy
Germany
Spain
o South America
Brazil
Argentina
Colombia
o Middle East & Africa
Iran
South Africa
UAE
Saudi Arabia
Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global remdesivir market.

Available Customizations:

With the given market data, we offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).